Skycovion: Withdrawal of the marketing authorisation application



SK Chemicals GmbH withdrew its application for a marketing authorisation of Skycovion for the prevention of coronavirus disease 2019 (COVID-19). 

The company withdrew the application on 1 September 2023.

Key facts

Product number
International non-proprietary name (INN) or common name
  • GBP510
Active substance
  • GBP510
Date of withdrawal
Company making the application
SK Chemicals GmbH
Withdrawal type
Initial authorisation

Related information on withdrawals

A question-and-answer (Q&A) document provides a summary of the CHMP's evaluation of the medicine at the time of the withdrawal of the application, and includes a link to the company's formal withdrawal letter.

An assessment report is published when the application is withdrawn after the first stage of the CHMP's evaluation is completed ('day 120').

How useful was this page?

Add your rating